This will get you thinking .....11 Sep 2020 19:34
Picture this !
Two weeks ago Matt Han**** receives a call from LSTM. ( You have the Holy Grail.)
He then calls Condor team who also confirm the Holy Grail.
Boris & Matt head off to Wetherby.
Big Al, you were right. You have the Holy Grail.
Boris then says sorry Big Al
this is too big for your little company to pull off the numbers we need.
Name your price we are going to bring in the Big Guns to scale this up.
Big Al says do we have a choice who is buying it ?
Boris,we will give you 24 hours call an emergency board meeting.
Later that night over a Fish & Chip supper, Avacta board are all sitting around, when Big Al tells them the news, we have got to sell the spit stick but we get a 10% royalty on a billion tests.
Which one of the Big guns shall we sell it to.
He looks around the table
30 minutes later GSK announced.
Avacta Board Members
GSK connection.
Eliot Forster
Non Executive Chairman
The early part of Dr Forster’s career was at GSK and then he went on to hold a number of senior roles in Pfizer.
Paul Fry
Non Executive Director
Paul has also served as Director of Global Finance Operations at Vodafone plc and spent more than 25 years at GlaxoSmithKline (“GSK”), where he held a number of senior roles including Head of Global Finance Services and Chief Financial Officer for GSK’s Italian pharmaceutical business.
Mike Owen
Senior Independent Director & Scientific Advisory Board Chairman
Dr Owen was Senior Vice President and global Head of Research of the Biopharmaceuticals R&D Unit at GlaxoSmithKline and was responsible for initiating and rapidly growing GSK’s robust pre-clinical and clinical therapeutic antibody pipeline during the last decade through in-house development as well as through acquisitions such as Domantis.
Amrik Basran
Chief Scientific Officer
Domantis was acquired by GSK in 2006, after which he became Head of Topical Delivery (Biopharm Discovery Unit), supporting the development of biotherapeutics across the GSK portfolio.
Sign In
Follow the stocks
